Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Filings indexed 453 across all filing types
Latest filing 2023-05-25 Regulatory Filings
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Resignation
Regulatory Filings
2023-05-25 English
Dividend
Regulatory Filings
2023-05-25 English
Dividend Updates
Regulatory Filings
2023-05-25 English
Financial Result Updates
Regulatory Filings
2023-05-25 English
Dividend
Regulatory Filings
2023-05-25 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India and BSE Limited regarding a newspaper advertisement for the transfer of equity shares to the Investor Education Protection Fund Authority (IEPF Authority). It references compliance with the Companies Act, 2013 and SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The content is about a regulatory compliance announcement related to unclaimed dividends and share transfers, not a financial report or detailed financial data. The document is about notifying the stock exchanges of a published notice and does not contain financial statements or detailed analysis. It is not a report itself but an announcement of a regulatory action. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.